# Olanzapine in Patients With Advanced Cancer and Weight Loss

> **NCT00489593** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 57 (actual)

## Conditions studied

- Advanced Cancer
- Weight Loss

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00489593
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489593, "Olanzapine in Patients With Advanced Cancer and Weight Loss". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00489593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*